Study of the photolytic and photocatalytic transformation of amiloride in water

Enhanced degradation of amiloride over Bi2FeNbO7/bisulfite process: Key factors and mechanism

Construction of Bi₂FeNbO₇/bisulfite system for abatement of pharmaceutical residue was achieved. An attempt to synthesize Bi₂FeNbO₇ through hydrothermal technique was confirmed by X-ray diffraction. The magnetic field experiment revealed that Bi₂FeNbO₇ possessed a saturation magnetization of 6.99 emu/g, indicating magnetic attributes of Bi₂FeNbO₇. Scanning electron microscopy images showed that Bi₂FeNbO₇ exhibited regular octahedra in the size of 200-300 nm. In a self-made device, the activation of sodium bisulfite using Bi₂FeNbO₇ for the disposal of amiloride has been carefully explored. The effects of solution pH, sodium bisulfite concentration, Bi₂FeNbO₇ dosage, amiloride concentration, coexisting ions, and water matrix on the performance of Bi₂FeNbO₇/bisulfite system was investigated. The catalytic performance of Bi₂FeNbO₇/bisulfite to degrade amiloride was considerably higher than that of traditional iron oxides. The maximum removal efficiency of amiloride was 97.9% in Bi₂FeNbO₇/bisulfite process. The involvement of Fe might be crucial for activating bisulfite to create active species. The dominating radical in Bi₂FeNbO₇/bisulfite process was identified as SO₃^•‒. With the help of UHPLC/MS/MS, three new degradation products of amiloride were found. Dehalogenation and deamination of amiloride might account for the formation of these transformation products. This work provides a highly efficient Bi₂FeNbO₇/bisulfite process for the disposal of pharmaceutical pollutants in water treatment.

Facile route for C–N/Nb2O5 nanonet synthesis based on 2-methylimidazole for visible-light driven photocatalytic degradation of Rhodamine B

Herein, we fabricated a C and N co-modified Nb₂O₅ nanonet structure (C–N/Nb₂O₅NNs) from niobium oxalate using 2-methylimidazole (Hmim) as a source for C and N via a simple hydrothermal route. The obtained nanonets are robust and cost-effective with excellent recycling stability. Compared with N-doped TiO₂ (N-TiO₂) and a Nb₂O₅ control sample (Nb₂O₅-CS), the resulting nanonets exhibited the highest performance toward the photocatalytic degradation of Rhodamine B (RhB) upon visible light irradiation (λ > 420 nm). Through this study, we revealed that the synergetic effects of C and N on the nanonet surface, which were effectively incorporated into the surface of the Nb₂O₅ nanonet structure, not only remarkably enhanced the visible light response by decreasing the bandgap to 2.9 eV but also improved the light utilization efficiency and photo-induced electron–hole pair separation efficiency of our nanonet structure. We also proposed that the presence of carbonate species (CO_x) and nitrogen species (NO_x) increased the population of generated holes (h⁺) that had the key role in the photodegradation mechanism of RhB, suggesting reasonable importance for the modification of Nb₂O₅ with C and N. This synergism offers a new view to reveal the origin of photodegradation processes, introducing h⁺ as a key intermediate. Our approach provides a new insight to design 2D nanostructures with potential applications in catalysis, solar energy conversion, and environmental protection.

Solar energy utilization: facile synthesis route of C–N/Nb₂O₅NNs using 2-methylimidazole to enhance its photocatalytic degradation towards RhB under visible irradiation.

DSC, FT-IR, NIR, NIR-PCA and NIR-ANOVA for determination of chemical stability of diuretic drugs: impact of excipients

It is well known that drugs can directly react with excipients. In addition, excipients can be a source of impurities that either directly react with drugs or catalyze their degradation. Thus, binary mixtures of three diuretics, torasemide, furosemide and amiloride with different excipients, i.e. citric acid anhydrous, povidone K25 (PVP), magnesium stearate (Mg stearate), lactose, D-mannitol, glycine, calcium hydrogen phosphate anhydrous (CaHPO4) and starch, were examined to detect interactions. High temperature and humidity or UV/VIS irradiation were applied as stressing conditions. Differential scanning calorimetry (DSC), FT-IR and NIR were used to adequately collect information. In addition, chemometric assessments of NIR signals with principal component analysis (PCA) and ANOVA were applied.

Between the excipients examined, lactose and starch did not show any interactions while citric acid, PVP, Mg stearate and glycine were peculiarly operative. Some of these interactions were shown without any stress, while others were caused or accelerated by high temperature and humidity, and less by UV/VIS light. Based on these results, potential mechanisms for the observed interactions were proposed Finally, we conclude that selection of appropriate excipients for torasemide, furosemide and amiloride is an important question to minimize their degradation processes, especially when new types of formulations are being manufactured.

Model-based analysis of coupled equilibrium-kinetic processes: indirect kinetic studies of thermodynamic parameters using the dynamic data

Thermodynamic studies of equilibrium chemical reactions linked with kinetic procedures are mostly impossible by traditional approaches. In this work, the new concept of generalized kinetic study of thermodynamic parameters is introduced for dynamic data. The examples of equilibria intertwined with kinetic chemical mechanisms include molecular charge transfer complex formation reactions, pH-dependent degradation of chemical compounds and tautomerization kinetics in micellar solutions. Model-based global analysis with the possibility of calculating and embedding the equilibrium and kinetic parameters into the fitting algorithm has allowed the complete analysis of the complex reaction mechanisms. After the fitting process, the optimal equilibrium and kinetic parameters together with an estimate of their standard deviations have been obtained. This work opens up a promising new avenue for obtaining equilibrium constants through the kinetic data analysis for the kinetic reactions that involve equilibrium processes.

Evaluation of direct and indirect photodegradation of mianserin with high-performance liquid chromatography and short-term bioassays

The widespread use of pharmaceuticals has lead to their detection in surface and ground waters. In the last year antidepressants in particular have shown very high growth dynamics of consumption and numerous research shows that these pharmaceuticals are detected in the environment and even in drinking water. Drugs and their metabolites can be subject to two types of photoreaction, direct and indirect photodegradation. These pharmaceuticals even at low concentration can have adverse effects on aquatic life, and the resulting photoproducts can be more toxic than parents compounds. The aim of this study was to evaluate the direct and indirect photodegradation of mianserin. The kinetics of the process and the identification of photoproducts were investigated by HPLC-PDA and HPLC-MS/MS, respectively. Ecotoxicity of mianserin before and after irradiation was assessed with a battery of assays with bacteria, protozoa and crustacea. The results show that mianserin was not toxic to Vibrio fischeri (Microtox), but its toxicity to protozoan Spirostomum ambiguum (Spirotox) and crustacean Thamnocephalus platyurus (Thamnotoxkit F(™)) was comparable to other antidepressants. On the basis of the results of the toxicity and HPLC before and after irradiation it can be seen that the decrease toxicity of mianserin was related only to a decrease of its concentration. The photoproducts had no impact to toxicity. The direct photodegradation of mianserin was more effective in UV/vis light than vis light. However the presence of humic acid in the indirect photodegradation increases the rate of degradation without regard to the kind of used light.

Some ozone advanced oxidation processes to improve the biological removal of selected pharmaceutical contaminants from urban wastewater

Removal of nine pharmaceutical compounds--acetaminophen (AAF), antipyrine (ANT), caffeine (CAF), carbamazepine (CRB), diclofenac (DCF), hydrochlorothiazide (HCT), ketorolac (KET), metoprolol (MET) and sulfamethoxazole (SMX)-spiked in a primary sedimentation effluent of a municipal wastewater has been studied with sequential aerobic biological and ozone advanced oxidation systems. Combinations of ozone, UVA black light and Fe(III) or Fe3O4 constituted the chemical systems. During the biological treatment (hydraulic residence time, HRT = 24 h), only AAF and CAF were completely eliminated, MET, SMX and HCT reached partial removal rates and the rest of compounds were completely refractory. With any ozone advanced oxidation process applied, the remaining pharmaceuticals disappear in less than 10 min. Fe3O4 or Fe(III) photocatalytic ozonation leads to 35% mineralization compared to 13% reached during ozonation alone after about 30-min reaction. Also, biodegradability of the treated wastewater increased 50% in the biological process plus another 150% after the ozonation processes. Both untreated and treated wastewater was non-toxic for Daphnia magna (D. magna) except when Fe(III) was used in photocatalytic ozonation. In this case, toxicity was likely due to the ferryoxalate formed in the process. Kinetic information on ozone processes reveals that pharmaceuticals at concentrations they have in urban wastewater are mainly removed through free radical oxidation.

TiO2-assisted photodegradation of pharmaceuticals — a review

Pharmaceutical compounds have been detected in the environment and potentially arise from the discharge of excreted and improperly disposed medication from sewage treatment facilities. In order to minimize environmental exposure of pharmaceutical residues, a potential technique to remove pharmaceuticals from water is the use of an advanced oxidation process (AOP) involving titanium dioxide (TiO2) photocatalysis. To evaluate the extent UV/TiO2 processes have been studied for pharmaceutical degradation, a literature search using the keywords ‘titanium dioxide’, ‘photocatalysis’, ‘advanced oxidation processes’, ‘pharmaceuticals’ and ‘degradation’ were used in the ISI Web of Knowledge TM, Scopus TM and ScienceDirect TM databases up to and including articles published on 23 November 2011. The degradation rates of pharmaceuticals under UV/TiO2 treatment were dependent on type and amount of TiO2 loading, pharmaceutical concentration, the presence of electron acceptors and pH. Complete mineralization under particular experimental conditions were reported for some pharmaceuticals; however, some experiments reported evolution of toxic intermediates during the photocatalytic process. It is concluded that the UV/TiO2 system is potentially a feasible wastewater treatment process, but careful consideration of the treatment time, the loading and the type of TiO2 (doped vs. undoped) used for a particular pharmaceutical is necessary for a successful application (198 words).

Hydrothermal growth of free standing TiO2 nanowire membranes for photocatalytic degradation of pharmaceuticals

Highly entangled TiO(2) nanowires were directly synthesized by hydrothermal growth on Ti substrates at 180 °C utilizing various organic solvents to oxidize Ti. The growth mechanism, microstructure and phase transition of TiO(2) nanowire membranes were investigated in detail. TiO(2) nanowires, with diameters of 10-20 nm and lengths up to 100 μm, show a phase transition from Type-B to anatase by annealing at 700 °C. Robust, free standing TiO(2) nanowire membranes with millimeter level thickness can be cleaved from Ti substrates or directly prepared from thin Ti foils. These porous TiO(2) membranes, while effective for mechanical microfiltration, can also photocatalytically degrade pharmaceuticals such as trimethoprim under UV irradiation.

The presence of pharmaceuticals in the environment due to human use--present knowledge and future challenges

Intensive research on pharmaceuticals in the environment started about 15 years ago. Since then a vast amount of literature has been published. The input and presence of active pharmaceutical ingredients (APIs) and their fate in the environment were and is still of high interest. As it has been extensively demonstrated that the active compounds are present in the environment some of the research interest has moved from analysis of the compounds, which is still undertaken, to effect studies in the lab and in field trials. It has been found that environmental concentrations can cause effects in wildlife if proper tools are applied for effect assessment. The question of mixture toxicity has gained more and more attention. It has been learned that classical tests may underestimate effects and risks. Work has been done in the field of risk assessment and risk management. As for risk management strategies to eliminate pharmaceuticals from wastewater or from the effluent of sewage treatment plants have been proposed and investigated. A tremendous amount of literature can now be found describing technical management measures such as oxidative or photolytic effluent treatment, filtering techniques, and application of charcoal. It has been learned however, that each of these approaches has its specific shortcomings. Therefore, additional approaches such as including people handling and using the compounds, and focusing on the properties of the compounds ("green pharmacy") came into focus. Accordingly, this review gives an overview of the present state of knowledge presenting typical results and lines of discussion. This review makes no claim to give a complete overview including the full detailed body of knowledge of pharmaceuticals in the environment. Rather, it addresses important and typical topics to stimulate discussion.